Regadenoson Impurities and its Related Products




Displaying 7 results of Regadenoson Impurities

Regadenoson is a pharmaceutical drug used in the diagnosis of heart diseases. Like any other drug, it may contain impurities that can affect its quality and safety. Regadenoson impurities refer to any unwanted substances that may be present in the drug, such as residual solvents, degradation products, or other contaminants. These impurities can impact the drug's efficacy, stability, and safety, and thus need to be monitored and controlled to ensure the drug's quality and safety. The identification, quantification, and control of regadenoson impurities are critical steps in the drug development and manufacturing process.

REGADENOSON IMPURITIES, IMPURITIES
1-[6-Amino-9-(3,4-dihydroxy-5-hydroxymethyl-tetrahydrofuran-2-yl)-9H-purin-2-yl]-1H-pyrazole-4-carboxylic acid


CAT No. : CS-O-47370
Mol F. : C14H15N7O6
Mol W. : 377.31 g/mol
Cas No. : Not Available
Stock : Enquire

REGADENOSON IMPURITIES, IMPURITIES
Regadenoson Impurity 1


CAT No. : CS-P-08221
Mol F. : C15H17N7O6
Mol W. : 391.34 g/mol
Cas No. : 1423073-21-5
Stock : Enquire

REGADENOSON IMPURITIES, IMPURITIES
Regadenoson Impurity 2


CAT No. : CS-P-08222
Mol F. : C16H20N8O5
Mol W. : 404.38 g/mol
Cas No. : 313348-31-1
Stock : Enquire

REGADENOSON IMPURITIES, IMPURITIES
Regadenoson Impurity 3


CAT No. : CS-P-08223
Mol F. : C14H15N7O6
Mol W. : 377.31 g/mol
Cas No. : 313348-29-7
Stock : Enquire

REGADENOSON IMPURITIES, IMPURITIES
Regadenoson Impurity 4


CAT No. : CS-P-08224
Mol F. : C15H18N8O5
Mol W. : 390.35 g/mol
Cas No. : 2015222-31-6
Stock : Enquire

REGADENOSON IMPURITIES, IMPURITIES
Regadenoson Impurity 8


CAT No. : CS-P-08225
Mol F. : Not Available
Mol W. : Not Available
Cas No. : Not Available
Stock : Enquire

REGADENOSON IMPURITIES, IMPURITIES
Regadenoson Impurity A (Acetate salt)


CAT No. : CS-EO-03817
Mol F. : C16H19N7O6 : C2H4O2
Mol W. : 405.4 : 60.1 g/mol
Cas No. : 313348-16-2 (Freebase)
Stock : Enquire